These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

277 related items for PubMed ID: 28511189

  • 41. Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance system.
    Stöhr W, Langer T, Kremers A, Bielack S, Lamprecht-Dinnesen A, Frey E, Beck JD, German Late Effects Working Group in the German Society of Pediatric Oncology and Hematology.
    Cancer Invest; 2005; 23(3):201-7. PubMed ID: 15945505
    [Abstract] [Full Text] [Related]

  • 42. [Ototoxicity of cis-diammine glycolato platinum, 254-S].
    Horiuchi M, Miyake H, Ota K.
    Gan To Kagaku Ryoho; 1992 Aug; 19(9):1327-32. PubMed ID: 1503488
    [Abstract] [Full Text] [Related]

  • 43. Cisplatin-based chemotherapy: Add high-frequency audiometry in the regimen.
    Arora R, Thakur JS, Azad RK, Mohindroo NK, Sharma DR, Seam RK.
    Indian J Cancer; 2009 Aug; 46(4):311-7. PubMed ID: 19749461
    [Abstract] [Full Text] [Related]

  • 44.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 45.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 46. Distortion product otoacoustic emissions: an objective technique for the screening of hearing loss in children treated with platin derivatives.
    Dhooge I, Dhooge C, Geukens S, De Clerck B, De Vel E, Vinck BM.
    Int J Audiol; 2006 Jun; 45(6):337-43. PubMed ID: 16777780
    [Abstract] [Full Text] [Related]

  • 47. Cisplatin-induced ototoxicity: audiometric findings and experimental cochlear pathology.
    Böheim K, Bichler E.
    Arch Otorhinolaryngol; 1985 Jun; 242(1):1-6. PubMed ID: 4041173
    [Abstract] [Full Text] [Related]

  • 48.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. [Changes in transitory evoked otoacoustic emissions in chemotherapy with cisplatin and 5FU].
    Beck A, Maurer J, Welkoborsky HJ, Mann W.
    HNO; 1992 Apr; 40(4):123-7. PubMed ID: 1601678
    [Abstract] [Full Text] [Related]

  • 53. [Evaluation of cisplatin ototoxicity by the audiometric curve in retinoblastoma].
    Toral-Martinñon R, Collado-Corona MA, Mora-Magaña I, Leal-Leal C, Gutiérrez-Castrellón P, González-de Leo S.
    Cir Cir; 2006 Apr; 74(2):79-82. PubMed ID: 16887078
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Protective effects of sodium thiosulfate for cisplatin-mediated ototoxicity in patients with head and neck cancer.
    Ishikawa E, Sugimoto H, Hatano M, Nakanishi Y, Tsuji A, Endo K, Kondo S, Wakisaka N, Murono S, Ito M, Yoshizaki T.
    Acta Otolaryngol; 2015 Sep; 135(9):919-24. PubMed ID: 25861690
    [Abstract] [Full Text] [Related]

  • 58. [Clinical study on the ototoxicity of cisplatin with distortion products].
    Orts Alborch M, García Callejo J, Morant Ventura A, Ferrer Baixauli F, Esparcia Navarro M, Marco Algarra J.
    Acta Otorrinolaringol Esp; 2000 Sep; 51(6):469-77. PubMed ID: 11142781
    [Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.